ACOG — Alpha Cognition Inc
The ticker ACOG represents Alpha Cognition Inc, listed on NASDAQ.
ACOG belongs to the HEALTHCARE sector and the BIOTECHNOLOGY industry.
To answer "what is ACOG worth" or "what is happening with Alpha Cognition Inc", VAQO shows a live price alongside technical analysis, relevant headlines and what other investors think.
VAQO's learning model reads seven technical indicators — short and long momentum, RSI, volatility, volume ratio, moving-average cross and position in the 52-week range — and turns them into transparent opportunity and risk scores.
What ACOG is
Alpha Cognition Inc. is a pioneering biopharmaceutical firm dedicated to revolutionizing the treatment landscape for neurodegenerative diseases, with a primary focus on Alzheimer's disease. The company's flagship candidate, ACOG-100, seeks to improve cognitive function and tackle significant unmet needs among the aging demographic. With a robust proprietary neuroscience platform and a deep commitment to rigorous research and development, Alpha Cognition is well-positioned for growth as it advances its clinical pipeline and explores new therapeutic avenues.
Alpha Cognition Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ACOG size and valuation
At roughly $195.6M, ACOG is a micro-cap.
Earnings per share are negative at -1.32, so there is no meaningful price-to-earnings multiple to quote.
Beta is 2.23: historically it has moved more than the market.
ACOG over the past year
Over the past year ACOG has traded between $4.50 and $10.14, and the current price sits at 67% of that range.
The 50-day average is $8.95 against a 200-day average of $6.90 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $18.00, 117.1% above it. A target is an aggregate of opinions, not a measurement.
How Alpha Cognition Inc (ACOG) is trading
Alpha Cognition Inc (ACOG) is up 1.72% at $8.29.
The session ranged from $8.00 to $8.48 — 5.8% of the share price — and the current price sits at 60% of that range.
Volume ran near 114.4K shares, about $948.3K of stock changing hands.
Traded alongside ACOG
Names traded alongside ACOG in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ACOG
Two statistical models run over ACOG inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
ACOG at a glance
- Symbol: ACOG
- Name: Alpha Cognition Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ACOG — frequently asked questions
What is the market cap of ACOG?
Alpha Cognition Inc has a market capitalisation of roughly $195.6M.
What is the 52-week range for ACOG?
ACOG has traded between $4.50 and $10.14 over the past year, with the current price at 67% of that range.
How much does ACOG stock cost today?
Alpha Cognition Inc (ACOG) trades at $8.29, a change of +1.72% in the latest session.
Is ACOG up or down today?
ACOG is up 1.72% in the latest session, at $8.29.
What is the daily trading range for ACOG?
ACOG traded between $8.00 and $8.48 in the latest session, and currently trades at $8.29.
What is the trading volume for ACOG?
ACOG traded roughly 114.4K shares in the latest session.
Which exchange is ACOG listed on?
ACOG is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ACOG stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ACOG figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Traded alongside ACOG
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08